Mattos Ana Carolina Musser Tavares de, Souza Jano Alves de, Moreira Pedro Ferreira, Jurno Mauro Eduardo, Velarde Luis Guilhermo Coca
Universidade Federal Fluminense, Hospital Universitário Antônio Pedro, Ambulatório de Cefaleia, Niterói RJ, Brasil.
Universidade Federal Fluminense, Departamento de Neurologia, Niterói RJ, Brasil.
Arq Neuropsiquiatr. 2017 Jul;75(7):446-450. doi: 10.1590/0004-282X20170069.
To analyze the applicability of the Portuguese version of ID-MigraineTM in a sample of Brazilian patients.
Patients with headache were recruited from the neurology outpatient clinic of a tertiary hospital and submitted to the ID-MigraineTM questionnaire. The diagnosis of headache was made according to the ICHD-2 criteria.
Of the 232 patients, 86% had migraine. The questionnaire showed a sensitivity of 92% (95%CI, 88% to 95%), specificity of 60% (95%CI, 43% to 77%) and a positive predictive value of 93% (95%CI, 89% to 96%).
Our results were similar to other international studies of the ID-MigraineTM application. The Portuguese version is considered easy to use, and an appropriate screening tool for migraine diagnosis in our sample.
Considering the characteristics of our health system, we can infer that this questionnaire would be beneficial in a Brazilian primary care setting; however, more studies are necessary.
分析葡萄牙语版ID-MigraineTM在巴西患者样本中的适用性。
从一家三级医院的神经科门诊招募头痛患者，并让他们填写ID-MigraineTM问卷。根据国际头痛疾病分类第二版（ICHD-2）标准进行头痛诊断。
在232名患者中，86%患有偏头痛。该问卷的灵敏度为92%（95%置信区间，88%至95%），特异度为60%（95%置信区间，43%至77%），阳性预测值为93%（95%置信区间，89%至96%）。
我们的结果与其他关于ID-MigraineTM应用的国际研究相似。葡萄牙语版被认为易于使用，是我们样本中偏头痛诊断的合适筛查工具。
考虑到我们卫生系统的特点，我们可以推断该问卷在巴西初级保健环境中会有益处；然而，还需要更多研究。
